← Back to Clinical Trials
Recruiting NCT07141238

NCT07141238 Microplastic Analysis in Pediatric Inflammatory Bowel Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07141238
Status Recruiting
Phase
Sponsor Medical University of Gdansk
Condition Crohn Disease
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2025-06-15
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
Environmental microplastic exposure

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2025-06-15 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are: Are microplastics detectable in different biological samples from children? Are there differences in microplastic burden between children with and without IBD? Researchers will collect biological samples including: intestinal tissue (from routine endoscopy), stool, urine, blood. Raman spectroscopy will be used to detect and characterize microplastics in each sample type. Participants will not receive any medication or intervention as part of this study. All samples will be collected during standard clinical procedures.

Eligibility Criteria

Inclusion Criteria: * Age \<18 years * Undergoing clinically indicated gastrointestinal endoscopy * For IBD group: confirmed diagnosis of Crohn's disease or ulcerative colitis * For control group: no current or past diagnosis of IBD Exclusion Criteria: * Age 18 years or older * Lack of informed consent from legal guardian * Lack of written assent from the participant if age ≥13 years

Contact & Investigator

Central Contact

Dominika Marszk, MD

✉ dsierdzinska@gumed.edu.pl

📞 +48609619101

Frequently Asked Questions

Who can join the NCT07141238 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Crohn Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07141238 currently recruiting?

Yes, NCT07141238 is actively recruiting participants. Contact the research team at dsierdzinska@gumed.edu.pl for enrollment information.

Where is the NCT07141238 trial being conducted?

This trial is being conducted at Gdansk, Poland.

Who is sponsoring the NCT07141238 clinical trial?

NCT07141238 is sponsored by Medical University of Gdansk. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology